Life Technologies Corporation (LIFE) - Financial and Strategic SWOT Analysis Review

Document Sample
Life Technologies Corporation (LIFE) - Financial and Strategic SWOT Analysis Review Powered By Docstoc
					           Life Technologies Corporation (LIFE) - Financial and Strategic SWOT
                                    Analysis Review
        Reference Code: GDPH94628FSA                                                                                             Publication Date: MAR 2013

          5791 Van Allen Way                                 Phone              +1 760 6037200                      Revenue          3,798.5 (million USD)
          Carlsbad, CA                                       Fax                +1 760 6026500                      Net Profit       430.86 (million USD)
          92008                                              Website            www.lifetechnologies.com            Employees        10,000 (Estimated)
                                                                                                                                     Pharmaceuticals           &
          United States                                      Exchange           LIFE [NASDAQ]                       Industry
                                                                                                                                     Healthcare

       Company Overview
       Life Technologies Corporation (Life Technologies) is a biotechnology company that offers a wide range of products and services
       to researchers. The products that the company offers include instruments, systems and reagents. It also offers custom services.
       Life Technologies provides technologies for next generation sequencing, capillary electrophoresis-based sequencing, sample
       preparation, mass spectrometry, ribonucleic acid (RNA) interference analysis, cell culture, functional genomics research,
       proteomics, and clinical diagnostic applications and cell biology applications. It also offers water testing analysis products.
       Key Executives                                                                SWOT Analysis
                      Name                                 Title                      Life Technologies Corporation, SWOT Analysis
         Gregory T. Lucier                   Chairman                                 Strengths                                Weaknesses
         George F. Adam, Jr.                 Director
                                                                                      Intellectual Property Portfolio          Patent Infringement Claims
         Raymond V. Dittamore                Director
                                                                                      Awards and Recognition
         Donald W. Grimm                     Director
         Balakrishnan S. Iyer                Director
        Source: Annual Report, Company Website, Primary and Secondary
                                                                                      Opportunities                            Threats
        Research, GlobalData
                                                                                      Strategic Agreements and                 Stringent Government
       Share Data                                                                     Collaborations                           Regulations
         Life Technologies Corporation
                                                                                      Inorganic Growth Strategies              Uncertain R&D Outcomes
        Share Price (USD) as on 22-Mar-                                63.99
        2013
                                                                                     Source: Annual Report, Company Website, Primary and Secondary Research,
        EPS (USD)                                                        2.40        GlobalData
        Market Cap (million USD)                                      10,903
        Enterprise Value (million USD)                                13,041
        Shares Outstanding (million)                                     170
       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData

       Financial Performance                                                         Recent Developments
                                                                                      Mar 21, 2013         Illumina Announces Favorable Outcome Of Its
                                                                                                           Patent Litigation Against Life Technologies
                                                                                      Feb 11, 2013         Life Technologies Receives FDA 510(k)
                                                                                                           Clearance For Diagnostic Use Of Sanger
                                                                                                           Sequencing Platform And HLA Typing Kits
                                                                                      Feb 04, 2013         Life Technologies Reports Revenue Of $3.8
                                                                                                           Billion In 2012
                                                                                      Jan 29, 2013         Life Technologies Establishes International
                                                                                                           Influenza Network
       Source: Annual Report, Company Website, Primary and Secondary                 Source: Annual Report, Company Website, Primary and Secondary Research,
       Research, GlobalData                                                          GlobalData




Life Technologies Corporation (LIFE) - Financial and Strategic                                                                    Reference Code: GDPH94628FSA
SWOT Analysis Review
Source : www.globalcompanyintelligence.com                                                                                                                         Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 4
          List of Figures ................................................................................................................................................................................. 4
       Section 1 - About the Company.......................................................................................................................................................... 5
       Life Technologies Corporation - Key Facts......................................................................................................................................... 5
       Life Technologies Corporation - Key Employees................................................................................................................................ 6
       Life Technologies Corporation - Key Employee Biographies.............................................................................................................. 7
       Life Technologies Corporation - Major Products and Services ........................................................................................................... 8
       Life Technologies Corporation - Medical Equipment Pipeline Products Data ..................................................................................... 9
          Life Technologies Corporation Pipeline Products by Equipment Type ........................................................................................... 9
          Life Technologies Corporation Pipeline Products by Development Stage .................................................................................... 10
       Life Technologies Corporation - History ........................................................................................................................................... 11
       Life Technologies Corporation - Company Statement ...................................................................................................................... 15
       Life Technologies Corporation - Locations And Subsidiaries ........................................................................................................... 17
          Head Office ................................................................................................................................................................................... 17
          Other Locations & Subsidiaries ..................................................................................................................................................... 17
          Joint Venture................................................................................................................................................................................. 19
       Section 2 – Company Analysis ......................................................................................................................................................... 20
       Life Technologies Corporation - Business Description ..................................................................................................................... 20
       Life Technologies Corporation - Corporate Strategy ........................................................................................................................ 22
       Life Technologies Corporation - SWOT Analysis ............................................................................................................................. 23
          SWOT Analysis - Overview........................................................................................................................................................... 23
          Life Technologies Corporation - Strengths.................................................................................................................................... 23
             Strength - Intellectual Property Portfolio .................................................................................................................................... 23
             Strength - Awards and Recognition ........................................................................................................................................... 23
             Strength - Broad Presence and Product Portfolio ..................................................................................................................... 23
          Life Technologies Corporation - Weaknesses .............................................................................................................................. 24
             Weakness - Patent Infringement Claims ................................................................................................................................... 24
          Life Technologies Corporation - Opportunities.............................................................................................................................. 24
             Opportunity - Strategic Agreements and Collaborations ........................................................................................................... 24
             Opportunity - Inorganic Growth Strategies ................................................................................................................................ 24
             Opportunity - New Product Launches........................................................................................................................................ 25
          Life Technologies Corporation - Threats ....................................................................................................................................... 25
             Threat - Stringent Government Regulations .............................................................................................................................. 25
             Threat - Uncertain R&D Outcomes ........................................................................................................................................... 25
             Threat - Highly Competitive Environment .................................................................................................................................. 25
       Life Technologies Corporation - Key Competitors ............................................................................................................................ 27
       Section 3 – Company Financial Ratios ............................................................................................................................................. 28
       Financial Ratios - Capital Market Ratios........................................................................................................................................... 28
       Financial Ratios - Annual Ratios ...................................................................................................................................................... 28
       Performance Chart ........................................................................................................................................................................... 30
       Financial Performance...................................................................................................................................................................... 30
       Financial Ratios - Interim Ratios....................................................................................................................................................... 31
       Financial Ratios - Ratio Charts ......................................................................................................................................................... 32
       Section 4 – Company’s Lifesciences Financial Deals and Alliances ................................................................................................ 33


Life Technologies Corporation (LIFE) - Financial and Strategic                                                                                                 Reference Code: GDPH94628FSA
SWOT Analysis Review
Source : www.globalcompanyintelligence.com                                                                                                                                                                Page 2
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
          Life Technologies Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 ............................................ 33
          Life Technologies Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013 ............................................ 34
          Life Technologies Corporation, Medical Equipment, Deals By Year, 2007 to YTD 2013 .............................................................. 35
          Life Technologies Corporation, Medical Equipment, Deals By Type, 2007 to YTD 2013 ............................................................. 36
       Life Technologies Corporation, Recent Deals Summary .................................................................................................................. 37
       Section 5 – Company’s Recent Developments ................................................................................................................................ 38
          Life Technologies Corporation, Recent Developments ................................................................................................................. 38
             Mar 21, 2013: Illumina Announces Favorable Outcome Of Its Patent Litigation Against Life Technologies.............................. 38
             Feb 11, 2013: Life Technologies Receives FDA 510(k) Clearance For Diagnostic Use Of Sanger Sequencing Platform And
             HLA Typing Kits ........................................................................................................................................................................ 38
             Feb 04, 2013: Life Technologies Reports Revenue Of $3.8 B
				
DOCUMENT INFO
Description: Life Technologies Corporation (Life Technologies) is a biotechnology company that offers a wide range of products and services to researchers. The products that the company offers include instruments, systems and reagents. It also offers custom services. Life Technologies provides technologies for next generation sequencing, capillary electrophoresis-based sequencing, sample preparation, mass spectrometry, ribonucleic acid (RNA) interference analysis, cell culture, functional genomics research, proteomics, and clinical diagnostic applications and cell biology applications. It also offers water testing analysis products.
BUY THIS DOCUMENT NOW PRICE: $125 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.